Abbott's New Glucose Test Strips Are First To Address Fatal Product Flaw
This article was originally published in The Gray Sheet
Executive SummaryWith a little extra push from FDA, Abbott gained 510(k) clearance May 14 for its new FreeStyle Lite blood glucose test strips, designed to remedy a potentially life threatening flaw in the product
You may also be interested in...
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.